- Status:
- Awaiting development
- Technology type:
- Medicine
- Decision:
- Selected
- Prioritisation programme:
- Medicines evaluation
- Rationale:
Criteria within the (VPAG) met as a new active substance.
- Process:
- STA Standard
Project Team
- Project lead
- Emily Richards
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 16 February 2026 | Topic prioritisation |
| 04 February 2026 | Awaiting development. Status change linked to topic prioritisation decision being set to Selected |
For further information on our processes and methods, please see our CHTE processes and methods manual